Combined gefitinib and pemetrexed overcome the acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small cell lung cancer

Min Wu(Anhui Medical University), Ying Zhang(Shantou University)
Molecular Medicine Reports
May 16, 2014
Cited by 32


Related Papers